BINDING PROFILE OF SM-9018, A NOVEL ANTIPSYCHOTIC CANDIDATE

被引:52
作者
KATO, T
HIROSE, A
OHNO, Y
SHIMIZU, H
TANAKA, H
NAKAMURA, M
机构
[1] Research Laboratories, Sumitomo Pharmaceuticals Co. Ltd., Osaka, 3-1-98, Kasugadenaka, Konohana-ku
关键词
D O I
10.1254/jjp.54.478
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study employed various receptor-binding assays to clarify the biochemical characteristics of SM-9018. SM-9018 possessed very high affinity for 5-HT2, D2 and 5-HT1A receptors (Ki=0.61, 1.4 and 2.9 nM, respectively), and it had moderate affinity for α1 and D1 receptors (K4 = 17 and 41 nM, respectively). However, SM-9018 had only negligible affinity for α2, opiate, glutamate, phencyclidine, benzodiazepine and GABAA receptors. These results suggest that SM-9018 may be a novel antipsychotic agent with binding affinity for 5-HT2 and 5-HT1A receptors. © 1990, The Japanese Pharmacological Society. All rights reserved.
引用
收藏
页码:478 / 481
页数:4
相关论文
共 13 条
[1]  
ALTER CA, 1986, BRAIN RES B, V16, P517
[2]  
BERSANI G, 1986, CURR THER RES CLIN E, V40, P492
[3]   EFFECT OF SEROTONIN ANTAGONISM IN SCHIZOPHRENIA - A PILOT-STUDY WITH SETOPERONE [J].
CEULEMANS, DLS ;
GELDERS, YG ;
HOPPENBROUWERS, MLJA ;
REYNTJENS, AJM ;
JANSSEN, PAJ .
PSYCHOPHARMACOLOGY, 1985, 85 (03) :329-332
[4]  
Feldman R.S., 1984, FUNDAMENTALS NEUROPS
[5]   DOPAMINE RECEPTOR SUBTYPE IMBALANCE IN SCHIZOPHRENIA [J].
HESS, EJ ;
BRACHA, HS ;
KLEINMAN, JE ;
CREESE, I .
LIFE SCIENCES, 1987, 40 (15) :1487-1497
[6]   PHARMACOLOGICAL ACTIONS OF SM-9018, A NEW NEUROLEPTIC DRUG WITH BOTH POTENT 5-HYDROXYTRYPTAMINE-2 AND DOPAMINE-2 ANTAGONISTIC ACTIONS [J].
HIROSE, A ;
KATO, T ;
OHNO, Y ;
SHIMIZU, H ;
TANAKA, H ;
NAKAMURA, M ;
KATSUBE, J .
JAPANESE JOURNAL OF PHARMACOLOGY, 1990, 53 (03) :321-329
[7]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[8]  
KITAMURA T, 1989, B JAPAN NEUROCHEM SO, V28, P498
[9]  
MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238
[10]  
MELTZER HY, 1989, PSYCHOPHARMACOL BULL, V25, P390